DOI QR코드

DOI QR Code

The Antibiotic Effect of Acetic acid on Helicobacter pylori

초산에 의한 마우스 위의 Helicobacter pylori 살균효과

  • Kim, Sun-Young (Department of Microbial Engineering. Konkuk University) ;
  • Kwon, Woo-Je (Department of Microbial Engineering. Konkuk University) ;
  • Kang, Sang-Mo (Department of Microbial Engineering. Konkuk University)
  • 김선영 (건국대학교 미생물공학과) ;
  • 권우제 (건국대학교 미생물공학과) ;
  • 강상모 (건국대학교 미생물공학과)
  • Received : 2010.08.16
  • Accepted : 2010.10.28
  • Published : 2010.12.31

Abstract

Helicobacter pylori (H. pylori) is the main causal bacteria occurring stomach diseases such as gastritis and gastric ulcer. These bacteria are found in most adults' stomach. Especially, 60~90% of H. pylori is found in Korean stomach. As a lot of curing methods have been applied to remove H. pylori and certain effects have been done but it's impossible to remove it perfectly with the existing medicines for curing. Therefore, it's very urgent to develop a certain substance showing more excellent effect than the existing medicines. In this study, it wasfound that organic acids can be accessed easily, inserted into mouth for curing and has excellent sterilizing effect among the substances showing excellent antibiotic power. Among them, acetic acid showed the most excellent effect. To confirm the refraining power against H. pylori, we performed tests through in vitro contact testing methods by concentration and tsta. In the result, H. pylori were terminated perfectly in the solution of acetic acid more than 0.3% within 1 minute. With a base of the result of In vitro test, It was performed in vivo test. As the results, H. pyloriwere terminated perfectly on 0.2% solution of acetic acid from the result of confirming through urease test, ELISA method and RT-PCR. Therefore, the result of this research will be very useful information in developing the functional foodstuffs using acetic acid in order to terminate H. pylori on the people's stomach, who suffers from H. pylori.

Helicobacter pylori(H. pylori)는 위 감염증의 주된 원인균으로, 위염 및 위궤양을 일이키는 균으로 알려져 있다. 대부분의 성인 남녀의 위에서 발견이 되면, 특히 한국 성인의 위에서 60~90% 정도 발견된다. H. pylori을 제균하기 위해 많은 치료 방법들이 시도되었고 어느 정도의 제균 활성은 있었으나, 완벽한 제균은 기존의 치료 약물로는 어렵다. 따라서 기존의 약물보다 더 효과가 좋은 물질의 개발이 시급한 상황이다. 본 연구에서는 항균 능력이 뛰어난 물질 중, 쉽게 접할 수 있고 경구투여로 치료가 용이하여 약재나 식품으로 응용할 수 있는 물질들중 유기산들이 살균능력이 뛰어난 것을 알았다. 그 중 초산이 가장 뛰어나 살균효과를 보였다. 초산의 H. pylori에 대한 억제 능력을 확인하기 위해 농도별, 시간별로 in vitro 접촉실험법으로 실험을 시행하였다. 그 결과 0.3% 이상의 초산 용액에서는 H. pylori가 1분 이내에 100% 사멸되었다. In vitro 실험 결과를 토대로 BALB/c mouse를 이용한 in vivo 실험을 하였다. H. pylori를 경구투여로 위해 접종하였다. 다음 감염된 것을 확인하고 초산용액을 각 군에 해당하는 농도에 준하여 0.1mL를 1일 1회 혹은 3회 경구투여하였다. 초산에 의한 H. pylori의 사멸 정도를 재배양 실험법, urease test 및 ELISA법으로 확인한 결과 초산용액 0.2% 식이에서 모두 사멸되었다. RT-PCR법으로 검정한 결과는 초산용액 0.2%에서 밴드가 나타났지만 이는 사멸된 균의 것으로 보이며, 0.3%에서 존재하지 않는 것으로 나타났다. RT-PCR법에서 0.2% 초산용액 식이에서는 H. pylori가 확인되는 것은 H. pylori의 사균이 위벽에 붙어 있다가 RT-PCR법으로 확인되는 것으로 보였다. 따라서 이 연구 결과가 세상 사람들의 절반이상이 감염되어 있는 H. pylori를 퇴치하는 데 매우 유용한 자료가 될 것이다. 또한 초산을 이용한 기능성 식품 개발에도 중요한 자료로써 활용될 것으로 생각된다.

Keywords

References

  1. Alain LS (2001) Antagonistic activity against Helicobacter pylori infection by the lactic acid bacteria. J Korean Public Health Assoc 27(1), 5-12.
  2. Andery PL, Edmond G, Alan F, Alain B, Jean-Paul B, Alex B, and Youri G (1995) Diagnosis of Helicobacter pylori Infection by PCR: Comparison with Other Invasive Techniques and Detection of cagA Gene in Gastric Biopsy Specimens. J Clin Microbiol 33(10), 2752-2756.
  3. Beuchat LR and Golden DA (1989) Antimicrobials occuring naturally in foods. Food Technol 43: 134-142.
  4. Cho YI, Park HS, Song KH, In HH, Yoon SW, Kim YRi, Lee JD, Jin CJ and Yoon SA (1998) Histopathological Features of H. pylori-induced Gastritis and Improvement of Gastritis after Erakication of H. pylori. Kor J Med 54, 158-167.
  5. Chung SH, Kim HJ, Ryu YS, Noh JH and Lee NH (2006) Effects of Anti-Helicobacter pylori IgY Powder to Protect Mice from Helicobacter pylori. Kor J Food Sci Technol 38(1), 93-98.
  6. Ding SZ, Jia BQ and Liu XG (1993) An urease enzyme linked immunosorbent assay for detection of Helicobacter pylori infection. Zhonghua Nei Ke Za Zhi, 32(5), 298-301.
  7. Eaton KA, Brooks CL, Morgan DR and Krakowaka S (1991) Essential orle of urease in pathogenesis of gastritis induced by Helicobacter pylori in gnotobiotic piglets. Infect Immun 59, 2470-2475.
  8. Ferrero RL, Hazell SL and Lee A (1998) The urease enzymes of Campylobacter pylori and a related bacterium. J Med Microbiol 27, 33-40.
  9. Freese E, Sheu CW and Galliers E (1973), Function of lipophilic acids as antimicrobial food additicves, Nature 241, 321-325 https://doi.org/10.1038/241321a0
  10. Goodwin CS and Armstrong JA (1990) Microbiological aspects of Helicobacter pylori (Campylobacter pylori). Eur J Clin Microbio Infect Dis 9, 1-13. https://doi.org/10.1007/BF01969526
  11. Goo MJ, Ki MR, Lee HR, Hong IH, Park JK, Yang HJ, Yuan DW, Hwang OK, Do SH, Yoo SE and Jeong KS (2008) Primary biliary cirrhosis, similar to that in human beings, in a male C57BL/6 mouse infected with Helicobacter pylori. Eur J Gastroenterol Hepatol 20(10), 1045-1048. https://doi.org/10.1097/MEG.0b013e3282f5e9db
  12. Graham DY, Lew GM, and Klein PD (1992) Effect of treatment of H. pylori infection and the long-term recurrence of gastric and duodenal ulcer. a randomized, controlled study, Ann Intern Med 116, 705-711. https://doi.org/10.7326/0003-4819-116-9-705
  13. Harper CG, Xu S, Rogers AB, Feng Y, Shen Z, Taylor NS, Dewhirst FE, Paster BJ, Miller M, Hurley J and Fox JG (2003) Isolation and characterization of novel Helicobacter spp. from the gastric mucosa of harp seals Phoca groenlandica. Dis Aquat Organ 57(1-2), 1-9. https://doi.org/10.3354/dao057001
  14. Ho SA, Hoyle JA, Lewis FA, Secker AD, Mapstone DCNP, Dixon MF, Wyatt JI, Tompkins DS, Taylor GR, and Quirke P (1991) Direct Polymerase Chain Reaction Test for Detection of Helicobacter pylori in Humans and Animals. J Clin Microbiol 29(11), 2543-2549.
  15. Jung HC (2001) Effects of Fermented Milk on the Helicobacter pylori Infection in Human stomach mucous, J Kor Public Health Assoc. 27(3), 193-197.
  16. Jung HK, Na YJ, Moon IH (2006) Changes of Helicobacter pylori-positive peptic ulcer disease: based on data from a general hospital. Kor J Gastroenterol 32, 1-8.
  17. Jin CJ, Park HS, Lee HW, Kim SR, Kang DG, Lee JS, Lee JD, Wang JH (2002) The Suppressive Effect of L. lactis CBT-8 on Helicobacter pylori Infection. KonKuk J Medical Sciences 12, 75-83.
  18. Kim JK (2005) Treatment of Helicobacter pylori Infection. Kor J Gastroenterol 46, 172-180.
  19. Kim NY (2005), Epidemiology and Transmission Route of Helicobacter pylori Infection, Kor J Gastroenterol 46, 153-158.
  20. Kim YC, Jung EJ, Kim EH, Jung DH, Jung SH, Yi DH, Kwon TJ and Kang SM (1998) Properties of acid tolerance of acid-resistant mutant Leuconostoc mesenteroides which was improved as Kimchi Starter. Kor J Appl Microbiol Biotechnol 26(4), 275-282.
  21. Kuipers EJ, Lundell L, Klinkenberg-Knol EC, Havu N, Festen HP, Liedman B, Lamers CB, Jansen JB, Dalenback J, Snel P, Nelis GF and Meuwissen SG (1996) Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 334(16), 1018-1022. https://doi.org/10.1056/NEJM199604183341603
  22. Lee A, Fox J, and Hazell S (1993) Pathogenicity of Helicobacter pylori: a perspective. Infect Immun 61, 1601-1610.
  23. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G and Dixon MF (1997) A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterol 112(4), 1386-1397. https://doi.org/10.1016/S0016-5085(97)70155-0
  24. Matsubara S, Shibata H, Ishikawa F, Yokokura T, Takahashi M, Sugimura T and Wakabayashi K (2003) Suppression of Helicobacter pylori-induced gastritis by green tea extract in Mongolian gerbils. Biochem Biophys Res Commun 310(3), 715-719. https://doi.org/10.1016/j.bbrc.2003.09.066
  25. Park YS, Kim YH (2006) The Effect of Medicinal Herb Extract on Antimicrobial Activity against Helicobacter pylori and Antioxidant Activity. J East Asian Soc Dietary Life 16(6), 199-206.
  26. Peng NJ, Lai KH, Lo GH and Hsu PI (2009) Comparison of noninvasive diagnostic tests for Helicobacter pylori Infection. Med Princ Pract 18, 57-61. https://doi.org/10.1159/000163048
  27. Roe IH, Nam SW, Yang MR, Myung NH, Kim JY and Shin JH (2002) The promising effect of egg yolk antibody (Immunoglobulin Yolk) on the treatment of Helicobacter pylori-associated gastric diseases. Kor J Gastroenterol 39(2), 260-268.
  28. Sawai N, Kita M, Kodama T, Tanahashi T, Yamaoka Y, Tagawa Y, Iwakura Y and Imanishi J (1999) Role of gamma interferon in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. Infect Immun 67(1), 279-285.
  29. Song JC, Cho EK, Park HJ, Shin WC and Choi SY (2002) Antimicrobial growth effect of various organic acids as preservatives on Helicobacter pylori. J Human Ecol 3(2), 44-56.
  30. Stefano Censini, Chiristina Lange, Zhaoying Xiang, Jean E. Crabtree, Paolo Ghiara, Mark Borodovsky, Rino Rappuoli, and Antonello Covacci (1996) cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci 93, 14648-14653. https://doi.org/10.1073/pnas.93.25.14648
  31. Tabak M, Artmom R, Potasman I, and Neeman I (1996) In vitro inhibition of Helicobacter pylori by extracts of thyme. J Appl Bacteriol 80, 667-672. https://doi.org/10.1111/j.1365-2672.1996.tb03272.x
  32. Urrestarazu GMI, Serrano CN, Piero R, Aristimuo OL, Lpez BY, Ramn PJ (1989) The urease test for the diagnosis of Campylobacter pylori infection. G E N. 43(3), 169-172.
  33. Warren JR and Marshall BJ (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1, 1279-1275.
  34. Yang JC, Shun CT, Chien CT and Wang TH (2008) Effective prevention and treatment of Helicobacter pylori infection using a combination of catechins and sialic acid in AGS cells and BALB/c mice. J Nutr 138(11), 2084-2090. https://doi.org/10.3945/jn.108.090985
  35. Yee YK, Koo MW, and Szeto ML (2002) Chinese tea consumption and lower risk of Helicobacter infection. J Gastroenterol Hepatol 17, 552-555. https://doi.org/10.1046/j.1440-1746.2002.02718.x
  36. Yoon YS, Lee SH, Baek NI, Kim HY and Park CH (2004) Inhibition of Cell Growth and Urease Activity of Helicobacter pylori by Medicinal plant Extracts. Kor J Biotechnol Bioeng. 19(3), 187-191.